Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6731 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
89-41 KOSELUGO AstraZeneca Pharmaceuticals LP Original drug not imported to China US Orange Book The 89th Batch of Reference Listed Drugs
89-42 Jakavi Novartis Europharm Limited Original drug not imported to China Approved in EU The 89th Batch of Reference Listed Drugs
89-43 / Pfizer Europe Original drug not imported to China Approved in EU The 89th Batch of Reference Listed Drugs
89-44 / Novartis Pharma S.A.S. Original drug not imported to China Approved in EU The 89th Batch of Reference Listed Drugs
89-45 / Novartis Pharma S.A.S. Original drug not imported to China Approved in EU The 89th Batch of Reference Listed Drugs
89-46 Canespor BAYER s.r.o. Original drug not imported to China Approved in EU The 89th Batch of Reference Listed Drugs
89-47 Crinone Merck Serono Limited Original drug not imported to China Approved in EU The 89th Batch of Reference Listed Drugs
89-48 / Hisamitsu Pharmaceutical Co., Inc. (久光製薬株式会社) Original drug not imported to China Approved in Japan The 89th Batch of Reference Listed Drugs
89-49 NAPAGELN Lotion 3% Teikoku Seiyaku Co., Ltd. (帝國製薬株式会社) Original drug not imported to China Approved in Japan The 89th Batch of Reference Listed Drugs
89-50 SEIBULE Sanwa Kagaku Kenkyusho Co., Ltd. (三和化学研究所株式会社) Original drug not imported to China Approved in Japan The 89th Batch of Reference Listed Drugs